Literature DB >> 15687314

Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial.

Vincenzo Squadrone1, Massimiliano Coha, Elisabetta Cerutti, Maria Maddalena Schellino, Piera Biolino, Paolo Occella, Giuseppe Belloni, Giuseppe Vilianis, Gilberto Fiore, Franco Cavallo, V Marco Ranieri.   

Abstract

CONTEXT: Hypoxemia complicates the recovery of 30% to 50% of patients after abdominal surgery; endotracheal intubation and mechanical ventilation may be required in 8% to 10% of cases, increasing morbidity and mortality and prolonging intensive care unit and hospital stay.
OBJECTIVE: To determine the effectiveness of continuous positive airway pressure compared with standard treatment in preventing the need for intubation and mechanical ventilation in patients who develop acute hypoxemia after elective major abdominal surgery. DESIGN AND
SETTING: Randomized, controlled, unblinded study with concealed allocation conducted between June 2002 and November 2003 at 15 intensive care units of the Piedmont Intensive Care Units Network in Italy. PATIENTS: Consecutive patients who developed severe hypoxemia after major elective abdominal surgery. The trial was stopped for efficacy after 209 patients had been enrolled.
INTERVENTIONS: Patients were randomly assigned to receive oxygen (n = 104) or oxygen plus continuous positive airway pressure (n = 105). MAIN OUTCOME MEASURES: The primary end point was incidence of endotracheal intubation; secondary end points were intensive care unit and hospital lengths of stay, incidence of pneumonia, infection and sepsis, and hospital mortality.
RESULTS: Patients who received oxygen plus continuous positive airway pressure had a lower intubation rate (1% vs 10%; P = .005; relative risk [RR], 0.099; 95% confidence interval [CI], 0.01-0.76) and had a lower occurrence rate of pneumonia (2% vs 10%, RR, 0.19; 95% CI, 0.04-0.88; P = .02), infection (3% vs 10%, RR, 0.27; 95% CI, 0.07-0.94; P = .03), and sepsis (2% vs 9%; RR, 0.22; 95% CI, 0.04-0.99; P = .03) than did patients treated with oxygen alone. Patients who received oxygen plus continuous positive airway pressure also spent fewer mean (SD) days in the intensive care unit (1.4 [1.6] vs 2.6 [4.2], P = .09) than patients treated with oxygen alone. The treatments did not affect the mean (SD) days that patients spent in the hospital (15 [13] vs 17 [15], respectively; P = .10). None of those treated with oxygen plus continuous positive airway pressure died in the hospital while 3 deaths occurred among those treated with oxygen alone (P = .12).
CONCLUSION: Continuous positive airway pressure may decrease the incidence of endotracheal intubation and other severe complications in patients who develop hypoxemia after elective major abdominal surgery.

Entities:  

Mesh:

Year:  2005        PMID: 15687314     DOI: 10.1001/jama.293.5.589

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  104 in total

1.  Prophylactic use of noninvasive positive pressure ventilation after video-assisted thoracoscopic surgery (VATS).

Authors:  Rahul J Anand
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

Review 2.  [Diagnostic assessment and treatment concepts for thoracic trauma].

Authors:  S Bölükbas; D Ghezel-Ahmadi; A-K Kwozalla; J Schirren
Journal:  Chirurg       Date:  2011-09       Impact factor: 0.955

3.  Noninvasive ventilation practice patterns for acute respiratory failure in Canadian tertiary care centres: A descriptive analysis.

Authors:  Genevieve Christina Digby; Sean P Keenan; Christopher M Parker; Tasnim Sinuff; Karen E Burns; Sangeeta Mehta; Juan J Ronco; Demetrios J Kutsogiannis; Louise Rose; Najib T Ayas; Luc R Berthiaume; Christine L D'Arsigny; Daniel E Stollery; John Muscedere
Journal:  Can Respir J       Date:  2015-10-15       Impact factor: 2.409

4.  Danger of helmet continuous positive airway pressure during failure of fresh gas source supply.

Authors:  Nicolò Patroniti; Maurizio Saini; Alberto Zanella; Stefano Isgrò; Antonio Pesenti
Journal:  Intensive Care Med       Date:  2006-11-18       Impact factor: 17.440

Review 5.  Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure.

Authors:  Bram Rochwerg; Laurent Brochard; Mark W Elliott; Dean Hess; Nicholas S Hill; Stefano Nava; Paolo Navalesi; Massimo Antonelli; Jan Brozek; Giorgio Conti; Miquel Ferrer; Kalpalatha Guntupalli; Samir Jaber; Sean Keenan; Jordi Mancebo; Sangeeta Mehta; Suhail Raoof
Journal:  Eur Respir J       Date:  2017-08-31       Impact factor: 16.671

6.  Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia.

Authors:  Anna Maria Brambilla; Stefano Aliberti; Elena Prina; Francesco Nicoli; Manuela Del Forno; Stefano Nava; Giovanni Ferrari; Francesco Corradi; Paolo Pelosi; Angelo Bignamini; Paolo Tarsia; Roberto Cosentini
Journal:  Intensive Care Med       Date:  2014-05-10       Impact factor: 17.440

7.  The Impact of Untreated Obstructive Sleep Apnea on Cardiopulmonary Complications in General and Vascular Surgery: A Cohort Study.

Authors:  Zaid M Abdelsattar; Samantha Hendren; Sandra L Wong; Darrell A Campbell; Satya Krishna Ramachandran
Journal:  Sleep       Date:  2015-08-01       Impact factor: 5.849

Review 8.  Noninvasive positive-pressure ventilation in acute respiratory failure.

Authors:  Oscar Peñuelas; Fernando Frutos-Vivar; Andrés Esteban
Journal:  CMAJ       Date:  2007-11-06       Impact factor: 8.262

Review 9.  Obstructive sleep apnea and oxygen therapy: a systematic review of the literature and meta-analysis.

Authors:  Vanita Mehta; Tajender S Vasu; Barbara Phillips; Frances Chung
Journal:  J Clin Sleep Med       Date:  2013-03-15       Impact factor: 4.062

10.  Helmet ventilation and carbon dioxide rebreathing: effects of adding a leak at the helmet ports.

Authors:  Fabrizio Racca; Lorenzo Appendini; Cesare Gregoretti; Ilaria Varese; Giacomo Berta; Ferdinando Vittone; Gabriela Ferreyra; Elisa Stra; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2008-05-06       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.